| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-07-28 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by Unleash Immuno Oncolytics, Inc. | sec.gov ↗ |
| 2026-07-28 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by Braci Elena Rosa | sec.gov ↗ |
| 2026-07-28 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by Katzman Daniel Eduardo | sec.gov ↗ |
| 2026-07-27 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by CK Life Sciences Intl (Holdings) Inc | sec.gov ↗ |
| 2026-07-23 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by CK Life Sciences Intl (Holdings) Inc | sec.gov ↗ |
| 2026-07-20 | 8-K 5.07 | Submission of matters to a vote of security holders | sec.gov ↗ |
| 2026-07-17 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by CK Life Sciences Intl (Holdings) Inc | sec.gov ↗ |
| 2026-07-17 | 8-K 5.03 | Amendments to articles of incorporation or bylaws; fiscal year change | sec.gov ↗ |
| 2026-07-17 | 8-K 3.03 | Material modification to rights of security holders | sec.gov ↗ |
8-K item codes from the filing header; 13D/G subject and filer verified against the filing index page.
